Prescribing HIV Prevention: Preexposure Prophylaxis (PrEP)
Originally Aired - Monday, May 22 • 1:00 PM - 2:00 PM
Location: Music City Center, Level 4, Grand Ballroom B
Event Information
Description:
Around 35,000 HIV infections occur annually in the U.S. despite widespread availability diverse options for HIV prevention. Antiretrovirals (ARVs) can reduce the spread of HIV as preexposure prophylaxis (PrEP) among individuals who are negative for HIV and eliminate risk of transmission from people living with HIV. Multiple options now exist for ARV PrEP including novel injectable PrEP. As professionals with prescriptive authority PAs are responsible for keeping up to date on evolving guidelines for ARV-based HIV prevention. Identification of risk factors as a personal and population level can be used by PAs to determine the risk profiles of each patient and determine a patient centered prevention plan. The presenter will assist the audience in becoming familiar with these medications to counsel patients on indication, use, and side effect profile alongside the other methods of HIV prevention including condoms and PEP.
Learning Objectives:
Type: CME
Create or Log in to My Conference Planner to see Videos and Resources.
{{chatHeaderContent}}
{{chatBodyContent}}
Your event registration does not include access to these session resources. Contact customercare@aapa.org for assistance with managing your registration.
This Session Has Not Started Yet
Be sure to come back after the session starts to have access to session resources.
